Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Leukemia
2:38
DARIC33 CAR T-cells in AML
Jacob Appelbaum
• 12 May 2021
6:10
Challenges of CAR T-cell therapy for AML: is CD38 the answer?
Lei Yu
• 3 Jun 2021
2:55
Identifying early predictors of neurotoxicity following CAR-T infusion
Jaap Boelens
• 26 May 2021
2:56
Allogenic NKX101 in r/r AML
James Trager
• 22 Feb 2021
3:07
Horizon scanning in anti-CD19 CAR T-cell therapy
Marco Alessandrini
• 20 May 2021
1:40
DARIC33: CAR T with an on/off switch
Jacob Appelbaum
• 12 May 2021
1:33
Improving education in cell therapy
Emanuele Ostuni
• 12 Apr 2021
2:29
CYCLE-1: next generation NKG2D-based CAR T-cells in AML/MDS
David Gilham
• 22 Feb 2021
4:13
CAR T-cells in adult ALL
Arnon Nagler
• 1 Feb 2021
4:31
Novel strategies to optimize CAR T-cell therapy
Arnon Nagler
• 1 Feb 2021
2:02
Infectious complications after CAR T-cell therapy
Joshua Hill
• 10 Feb 2021
3:21
CAR-T trials to watch in China
Jianxiang Wang
• 2 Feb 2021
2:19
Progression of CAR-T trials in China
Jianxiang Wang
• 2 Feb 2021
3:30
Second CD19-targeted CAR T-cell infusion for R/R B-cell malignancies
Jordan Gauthier
• 28 Jan 2021
3:19
Infection prevention in patients receiving CAR T-cells
Joshua Hill
• 10 Feb 2021
4:32
CAR-T in myeloma: key players in the therapeutic landscape
Mohamad Mohty
• 26 Jan 2021
Previous
1
2
3
Next